Evaluation of pharmaceutical intervention in direct-acting antiviral agents for hepatitis C virus infected patients in an ambulatory setting: a retrospective analysis

• Hoofdauteurs: Haruna Yamamoto (Auteur), Hiroaki Ikesue (Auteur), Mai Ikemura (Auteur), Rieko Miura (Auteur), Kazumi Fujita (Auteur), Hobyung Chung (Auteur), Yoshiki Suginoshita (Auteur), Tetsuro Inokuma (Auteur), Tohru Hashida (Auteur)
• Formaat: Boek
• Gepubliceerd in: BMC, 2018-07-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Abstract Background Direct-acting antivirals (DAAs) are known to improve tolerability and have higher efficacy and shorter treatment durations compared with conventional interferon (IFN)-based treatments for hepatitis C virus (HCV) infection. Management of drug interactions and maintenance of patien...